openPR Logo
Press release

Depression Screening Market 2019: Competitor Analysis By Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co.,Ltd., Pfizer Inc., GlaxoSmithKline plc, Alkermes, ALLERGAN, Janssen Global Services, LLC., Solvay

05-21-2019 02:40 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Depression Screening Market

Depression Screening Market

Global Depression Screening Market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios. The Depression Screening Market report also presents the vendor landscape and a corresponding detailed analysis of the major vendors operating in the market. Global Depression Screening Market 2026, presents critical information and factual data about the market, providing an overall statistical study of the Depression Screening Market on the basis of market drivers, Market limitations, and its future prospects.

Global Depression Screening Market is expected to rise from its initial estimated value of USD 9043.06 million in 2018 to an estimated value of USD 12968.84 million by 2026 registering a CAGR of 4.61% in the forecast period of 2019-2026. This rise in the market can be attributed to the growing patient population with the medical conditions such as anxiety, depressions and mental disorders.

Get Free Sample Report @

Key Market Competitors:

Few of the major market competitors currently working in the global depression screening market are

• Johnson & Johnson Services Inc.,

• AstraZeneca,

• Bristol-Myers Squibb Company,

• Eli Lilly and Company,

• F. Hoffmann-La Roche Ltd.,

• Novartis AG,

• Otsuka Holdings Co.,Ltd.,

• Pfizer Inc.,

• GlaxoSmithKline plc,

• Alkermes,


• Janssen Global Services, LLC.,

• Solvay,

• Meiji Holdings Company, Ltd.,

• Abbott,

• Jazz Pharmaceuticals, Inc.,

• AbbVie Inc.,

• Vertical Pharmaceuticals, LLC,

• ACADIA Pharmaceuticals Inc.,

• Medtronic,

• Bausch Health.,

• Validus Pharmaceuticals LLC,

• Alfasigma USA Inc.,

• Merck KGaA,

• Island Health,

• Homewood Health, Inc.,



Key Developments in the Market:

• In November 2018, The Health Department announced the launch of their new campaign whose main aim is expand the treatment and screening of depression in primary care setting. The campaign main motive is to fill the gap between the care taker centers and hospitals and help the providers to guide how they can ask the patients about the common symptoms of depression. This campaign will help people to be more open about their problems with the doctors and get better treatment.

• In October 2017, Cedars-Sinai Medical Center announced the launch of their new Postpartum Depression Screening Program which is specially designed for the new mothers. In this, the new mother after the two days of giving birth have to answer 9 questions which will help the doctor to analyze whether there is any symptoms of the postpartum depression or not. The main aim of the program is to provide good treatment and care to the patients if they are suffering from such depression.

Market Definition: Global Depression Screening Market

Depression is a serious medical illness. It may leads to various psychotherapeutic conditions which can be classified as abnormal behavior, thoughts and feelings. These abnormal conditions sometimes occur for specific amount of time, which leads to distress or emotional or physical impairment. The causes of mental disorders are often unclear. The screening consist of physical exam is usually to rule out another medical cause for depression. The depression screening majorly focuses on neurological and endocrine systems.

Market Drivers

• Increasing cases of mental disorders is driving the growth of this market

• Rise in adoption of new therapies and treatments is another factor driving market

Market Restraints

• Less awareness among population about mental health disorders is restraining the market

• Less availability of treatment related to depression in the developing countries is another important factor restraining market.

Get 10% Discount Instant Mail us @


By Disease Type

o Anxiety
o Mood Disorders
o Depression
o Bipolar Disorders
o Psychotic Disorders
o Eating Disorders
o Other Disorders

By Diagnosis

o Psychological Test
o Lab Tests
o Depression Screening Tests
o Others

By Treatment

o Medication

 Anti-Anxiety Medications
 Antidepressants
 Antipsychotic Medications
 Stimulants
 Anti-Seizures Medications
 Others

o Brain-Stimulation Treatments

 Vagus Nerve Stimulation (VNS)
 Repetitive Transcranial Magnetic Stimulation (rTMS)
 Magnetic Seizure Therapy (MST)

o Deep Brain Stimulation

By End User

o Hospitals
o Specialized Clinics
o Ambulatory Surgical Centers
o Others

By Geography

o North America

o Europe

o Asia-Pacific

o South America

For More Details In-Depth Inquiry @

Competitive Analysis:

Global depression screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global depression screening market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

• Current and future of global depression screening market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

• Regions/Countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

• All segmentation provided above in this report is represented at country level

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Table of Contents:

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports

Download Detailed TOC @

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research
Tel: +1-888-387-2818

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Depression Screening Market 2019: Competitor Analysis By Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co.,Ltd., Pfizer Inc., GlaxoSmithKline plc, Alkermes, ALLERGAN, Janssen Global Services, LLC., Solvay here

News-ID: 1747625 • Views: 578

More Releases from Data Bridge Market Research

Water Treatment Chemicals Market 2020 : Witnessing Enormous Growth and Booming W …
The Global Water Treatment Chemicals Market is expected to reach USD 61.86 billion by 2026, from USD 43.6 billion in 2017 growing at a CAGR of 7.9 % during the forecast period of 2020 to 2026 Moreover increasing industrial activities and growth in world population are augmenting the market for the water treatment chemicals across the globe. Increasing water treatment chemicals prices and presence of alternate treatment technologies are predicted to
Robotic Process Automation (RPA) Market Competitive Outlook: Automation Anywhere …
A new business intelligence report released by Data Bridge Market research with titled "Global Robotic process automation Market" (covering USA, Europe, China, Japan, India, South East Asia and etc) that targets and provides comprehensive market analysis with future prospects to 2026. This rise in the market can be attributed due to rising popularity and attractiveness of enterprise resource planning which is driving the needs of the business to
Digital Assurance Market Competitive Outlook: Atos, Accenture, Capgemini, Cignit …
Data Bridge Market researchhas recently released expansive research on Global Digital Assurance Market with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis. The report endows with wide-ranging statistical analysis of the market's continuous developments, capacity, production, production value, cost/profit, supply/demand and import/export. This market report provides best solutions for strategy development and implementation depending on client's needs to extract tangible
Rear E Axle Market Future Outlook | ZF Friedrichshafen AG, Schaeffler AG,Contine …
Front rear E axle market will register the growth rate of 23.50% for the forecast period of 2020 to 2027. Rising usage of E-axle in ICE vehicles is expected to create new opportunity for the market. Growing sales of electric and hybrid vehicles is expected to enhance the market growth. Some of the other factors such as increasing cost of the fuels, strict emissions rules to decrease the vehicle weight

All 5 Releases

More Releases for Depression

Global Depression Treatment Therapy Market Research and Forecast, 2018-2023
Increasing Cases of Depression Will Accentuate the Growth of Global Depression Treatment Therapy Market According to OMR analysis, the global depression treatment therapy market is estimated to grow with a significant CAGR during the forecast period. The introduction of virtual reality in the treatment of disorders such as post-traumatic stress disorders is driving the market. However, North America and Europe region are currently leading the market. They make up for
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive
Depression Therapeutics Market Forecast till 2025
Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior. Antidepressants cover a wide range of drug categories, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants
Global Depression Drugs Market Analysis & Forecast with Upcoming Trends 2022
Global Info Reports has published its new and latest market report based on thorough research on the Depression Drugs Market. This detailed, all-inclusive report renders an integrated approach to growth of the market along with an elaborate and accurate analysis of the complete competitive situation of this market on a global level with the key market trends and newest technologies, being a major part in the market’s growth during the
Depression Drug Market: Global Depression Drug Forecast Will Reach $16.8 billion …
Zion Market Research has published a new report titled “Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the global depression drug market was valued at USD 14.51 billion in 2014 and is expected to generate revenue of USD 16.8 billion by end of 2020, growing at a CAGR of 2.50%
Animal Depression Medication Market – Global Industry Analysis 2024
Animal Depression Medication Market Overview Emotions may be described as subjective, conscious experiences characterized by psychophysiological expressions, mental states, and biological reactions. Several tests such as cognitive bias test and leaned helplessness models have been developed to understand feelings of optimism and pessimism in animals. Cognitive biases have been shown in wide range of species, including rats, dogs, cats, sheep, and chicks. Get Free PDF Research Brochure for more Professional and Technical